These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19591935)

  • 1. Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems.
    Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
    Neurobiol Dis; 2009 Oct; 36(1):70-80. PubMed ID: 19591935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
    Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
    Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior.
    Fogaça MV; Aguiar DC; Moreira FA; Guimarães FS
    Neuropharmacology; 2012 Aug; 63(2):202-10. PubMed ID: 22691536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications.
    Tzavara ET; Li DL; Moutsimilli L; Bisogno T; Di Marzo V; Phebus LA; Nomikos GG; Giros B
    Biol Psychiatry; 2006 Mar; 59(6):508-15. PubMed ID: 16199010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors.
    Batista PA; Fogaça MV; Guimarães FS
    Behav Brain Res; 2015 Oct; 293():182-8. PubMed ID: 26187694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.
    Lee SH; Ledri M; Tóth B; Marchionni I; Henstridge CM; Dudok B; Kenesei K; Barna L; Szabó SI; Renkecz T; Oberoi M; Watanabe M; Limoli CL; Horvai G; Soltesz I; Katona I
    J Neurosci; 2015 Jul; 35(27):10039-57. PubMed ID: 26157003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems.
    Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Di Marzo V; Drago F
    Pharmacol Res; 2010 Jun; 61(6):531-6. PubMed ID: 20149873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
    Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
    Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum.
    Musella A; De Chiara V; Rossi S; Cavasinni F; Castelli M; Cantarella C; Mataluni G; Bernardi G; Centonze D
    Neuroscience; 2010 May; 167(3):864-71. PubMed ID: 20219639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
    Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
    Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic-like properties of the anandamide transport inhibitor AM404.
    Bortolato M; Campolongo P; Mangieri RA; Scattoni ML; Frau R; Trezza V; La Rana G; Russo R; Calignano A; Gessa GL; Cuomo V; Piomelli D
    Neuropsychopharmacology; 2006 Dec; 31(12):2652-9. PubMed ID: 16541083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
    Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V
    Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-training anandamide infusion within the basolateral amygdala impairs plus-maze discriminative avoidance task in rats.
    Munguba H; Cabral A; Leão AH; Barbosa FF; Izídio GS; Ribeiro AM; Silva RH
    Neurobiol Learn Mem; 2011 May; 95(4):527-33. PubMed ID: 21440651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors.
    Umathe SN; Manna SS; Utturwar KS; Jain NS
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1191-9. PubMed ID: 19580839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids induce apathetic and impulsive patterns of choice through CB1 receptors and TRPV1 channels.
    Fatahi Z; Reisi Z; Rainer G; Haghparast A; Khani A
    Neuropharmacology; 2018 May; 133():75-84. PubMed ID: 29355640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
    Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V
    Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.
    Rossi F; Siniscalco D; Luongo L; De Petrocellis L; Bellini G; Petrosino S; Torella M; Santoro C; Nobili B; Perrotta S; Di Marzo V; Maione S
    Bone; 2009 Mar; 44(3):476-84. PubMed ID: 19059369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam.
    Leggio GM; Torrisi SA; Castorina A; Platania CB; Impellizzeri AA; Fidilio A; Caraci F; Bucolo C; Drago F; Salomone S
    Eur Neuropsychopharmacol; 2015 Sep; 25(9):1427-36. PubMed ID: 25482686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.